Abstract
Background. The so-called “intact parathyroid hormone (iPTH)” assay detects large C-terminal PTH fragments that are lacking several N-terminal amino acid residues in addition to 1-84 PTH molecules.
Methods. Blood samples were obtained from 65 predialysis patients (male, 35; female, 30) and 109 dialysis patients (male, 73; female, 36). The plasma 1-84 PTH levels were determined by a specific immunoradiometric assay (IRMA).
Results. The ratio of 1-84 PTH/iPTH did not show a significant correlation with glomerular filtration rate (GFR) among patients with a GFR of more than 80 ml/min, while it showed a positive correlation with GFR among patients with a GFR of less than 80 ml/min. The ratio of 1-84 PTH/iPTH demonstrated a significant tendency to decrease in the order of patients with normal renal function (0.928 ± 0.182), those with renal dysfunction (0.836 ± 0.186; P < 0.05 vs patients with GFR > 80 ml/min [i.e., normal renal function]), and those with maintenance hemodialysis (0.618 ± 0.123; P < 0.01 vs patients with GFR > 80 ml/min). The plasma levels of 1-84 PTH and conventional iPTH showed a close correlation in dialysis patients. Neither 1-84 PTH levels nor secondary parameters calculated from them showed a better correlation with bone metabolic markers than iPTH levels.
Conclusions. Circulating large C-terminal PTH fragment levels are increased in uremic patients. However, this noninvasive study failed to demonstrate the superiority of the specific 1-84 assay compared with the conventional iPTH assay to evaluate bone metabolism.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kazama, J., Omori, T., Ei, I. et al. Circulating 1-84 PTH and large C-terminal PTH fragment levels in uremia. Clin Exp Nephrol 7, 144–149 (2003). https://doi.org/10.1007/s10157-003-0226-2
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10157-003-0226-2